Guy Broadbent joins Xcellerex
This article was originally published in Scrip
Xcellerex (US) has named Guy Broadbent president and CEO. He succeeds Joseph Zakrzewski, who will remain as the company's chairman. Mr Broadbent joins from Thermo Fisher Scientific where he held a number of senior positions, including president of the laboratory products division and, most recently, senior vice-president of corporate development.
You may also be interested in...
Despite leading multinational pharma firms including AstraZeneca again delivering double-digit growth in China, the impact of coronavirus and an expanding volume-based purchasing scheme begin to surface.
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.
The UK Department of Health and Social Care recently asked medical device and pharmaceutical companies to establish contingency measures in case of supply problems post-Brexit.